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Molluscum contagiosum: an unusual
complication of tattooing
Molluscum contagiosum is a common viral disease of the skin. The
causative virus, from its size, shape, fine structure, cytoplasmic site
of replication, and characteristic inclusion body, appears to be a
member of the pox group. Transmission is thought to occur by direct
contact, though the incubation period is not known and innoculation
experiments have failed. Although any infective condition might
theoretically be innoculated by tattooing, in practice the only diseases
that have been reported are pyogenic infection, syphylis, tuberculosis,
serum hepatitis, and one case of viral warts.'
Case report
A 20-year-old mnan presented in September 1981. Seven months earlier
he had had a tattoo professionally performed on his left upper arm with a
single needle, using carbon, scarlet lake, and chlorinated copper pigments.
Within three months of the tattooing a crop of seven lesions of molluscum
contagiosum localised to the area of tattoo performed with carbon pigment
had appeared. These had persisted until the tirne of consultation (figure).
Direct microscopy of an unstained curetted lesion on a slide confirmed the
diagnosis of molluscum contagiosum. A similar tattoo performed profession-
ally on his right upper arm three years earlier had had no sequelae. He had
had no other serious illnesses or skin diseases im the past apart from four
common warts present on the palm of his right hand for four years. There
was no family history of atopic disease. No treatment was given, and the
lesions disappeared spontaneously within six months.
Molluscum contagiosum localised to area of tattoo
performed with carbon pigment.
Comment
In this patient the virions of molluscum contagiosum were pre-
sumably innoculated at the time of tattooing and must have been
present within the tattoo pigment, which consisted of charcoal
suspended in ammoniacal solution containing phenol. To date no
similar cases have been reported, which suggests that a particular
host environment is required to establish the growth of molluscum
contagiosum.
There is some clinical evidence that molluscum contagiosum is
spread by direct contact. Seven patients under the care of one surgeon
were infected -with molluscum contagiosum at the site of operation.2
Three women attending a Turkish bath in Sheffield recently developed
multiple lesions of molluscum contagiosum at the sites where common
salt was rubbed in, suggesting that the salt contained the virus
particles (unpublished observation). There have been few reports of
molluscum contagiosum affecting more than one member ofa family,3'
however, again suggesting that a particular host environment is
required. Molluscum contagiosum is thought to occur more commonly
in atopic people, though there are only isolated case reports to confirm
this and there is dispute over whether the lesions of molluscum
contagiosum affect involved or uninvolved areas of active atopic
dermatitis.5
This isolated appearance of molluscum contagiosum occurring as
a result of professional tattooing, localised to one pigment of the
tattoo, warrants further investigation into the host environment
required for the establishment of this virus.
Scutt RWB. The medical hazards of tattooing. Br J Hosp Med 1972;8:
194-202.
2 Paton EP. Seven cases in which operation wounds were infected with
molluscum contagiosum. Westminster Hospital Report 1909 ;16:11-5.
3 Calvert JW. Molluscum contagiosum. Arch Dermatol 1972;106:601.
4Overfield TM, Brody JA. An epidemiological study of molluscum con-
tagiosum in Ankorage, Alaska. J Pediatr 1966;69:640-2.
5 Block SH. The association of molluscum contagiosum and infantile
eczema. MedJ3 Aust 1972;2:626-7.
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Hypocalcaemia-induced epilepsy
during lactation
Hypocalcaemia is a rare but well-recognised cause of grand mal
convulsions' and may come to light only as a result of routine bio-
chemical screening. In the present case grand mal convulsions
occurred due to hypocalcaemia after a prolonged period of lactation.
Case report
A 28-year-old woman presented with a history of four grand mal fits
within the previous month. During this period she had felt unusually tired
and had suffered from generalised headaches, poor memory, and paraesthesiae
in the hands and legs. There was no history of birth trauma, head injury, or
epilepsy. She had given birth to her first child by caesarean section in
February 1980 and had subsequently been breast feeding up to the time of
admission eight months later.
Her father suffered from grand mal epilepsy and her sister had petit mal
seizures. She was the youngest of four sisters, all of whom had achieved
much greater academic success than her.
On examination she was stocky, being 160 cm in height (smaller than her
sisters) and weighing 57-2 kg. Her teeth showed a considerable number of
minor enamel defects. Chvostek's sign and Trousseau's phenomenon did not
occur. The rest of the clinical examination was normal.
The results of investigations were as follows: haemoglobin concentration
12-1 g/dl; bicarbonate 28 mmol(mEq)/l; calcium between 145 and 1-54
mmol/l (5-8 and 6-16 mg/100 ml) on several occasions; phosphate 1-89
mmol/l (5-85 mg/100 ml); alkaline phosphatase 490 IU/l; albumin 42 g/l;
total protein 74 g/l; magnesium 0-69 mmol/l (1.68 mg/100 ml); and para-
thyroid hormone <0-1 Kg/l (normal range 0. 1-0-73 itg/l). A cyclic adenosine
monophosphate stimulation test yielded positive results. Autoantibodies were
absent on screening, and chest and skull x-ray films and a computed tomo-
gram were normal, with no sign of intracranial calcification. Cerebrospinal
fluid was at a pressure of 120 mm water and of normal constitution. Electro-
encephalography showed moderate bilateral abnormalities with paroxysmal
features. Psychological testing yielded an IQ of 81 with poorer than expected
verbal and non-verbal memory function.
Primary hypoparathyroidism was diagnosed, and she was treated initially
with intravenous calcium gluconate and then maintained on la-hydroxy-
cholecalciferol 2 jLg daily and a high-calcium diet. The serum calcium concen-
tration returned to normal. Anticonvulsants were stopped, and she remained
free of fits.
Comment
Her fits were thought to be due to hypocalcaemia rather than
idiopathic epilepsy because, firstly, the plasma calcium concentration
was sufficiently low to cause convulsions; secondly, the symptoms of
hypocalcaemia, such as paraesthesiae, had begun at the time of the
first convulsion; and, thirdly, she remained completely free of fits
without anticonvulsant medication once the hypocalcaemia had been
corrected. The absence offrank tetany and ofTrousseau's phenomenon
and Chvostek's sign is unusual in severe hypocalcaemia but not
unknown.2
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The main interest in this case is that the patient's fits started only
towards the end of a prolonged period of lactation, during which
calcium losses would be expected to increase.3 We speculate that
lactation was a major factor in inducing the convulsions since it may
have reduced an already low plasma calcium concentration to epilepto-
genic levels. A further possibility is that she had a familial tendency
to epilepsy that became manifest only in the hypocalcaemic state.
Many neurologists do not perform routine biochemical screening in
patients presenting with epilepsy: although it may not be justifiable
economically to measure plasma calcium concentrations in every
patient with epilepsy, we suggest that it is wise to exclude hypo-
calcaemia in any patient who presents with convulsions during
lactation, even if there is a family history of epilepsy.
Simpson JA. The neurological complications of hypoparathyroidism.
Brain 1952;75 :76-90.
2 O'Donovan DK. The diagnosis of latent tetany with observations on the
effect of calciferol. Br MedJ 1948;ii:900-2.
3 Fourman P, Royer P, Levell MJ, Morgan BM. Calcium metabolism and
the bone. Oxford: Blackwell, 1968:62-4.
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Double-blind controlled study of
primidone in essential tremor:
preliminary results
Essential tremor is a common, monosymptomatic disorder for which
no predictable and completely satisfactory drug treatment is available.'
Primidone, a well-established anticonvulsant, has been reported to be
highly effective,2 3 but this has been based on only uncontrolled
clinical observations. We report the preliminary results of a double-
blind placebo-controlled study of primidone in essential tremor
obtained using an objective recording technique.
Patients, methods, and results
We studied 11 patients with moderate to severe essential tremor aged
15-82 (mean 57) years. Mean duration of symptomatic tremor was 10-6
(range 4-24) years. The patients were not taking any other medication.
Primidone and placebo were given in randomised order, according to a
cross-over design, for five weeks each. Two patients received both primidone
and placebo for two weeks only. Primidone was started at 62-5 mg daily
and increased by 62-5 mg every day up to a maximum of 250 mg three times
a day.
At the end of each five-week regimen tremor was assessed under standar-
dised conditions by using piezoresistive linear accelerometers (ENDEVCO
7265/10) attached at the dorsum of each hand, which were maintained
outstretched and pronated with the arms supported to the wrists. Derived
signals were computed off-line using a spectrum analyser, as described.4
Measurements were taken as the root mean square magnitude of acceleration
and frequency (Hz) of the dominant peak(s) in the spectrum. The unit of
acceleration was referred to earth's gravity (g= 981 cm/s2). Only data derived
from the hand that was more severely affected while placebo was being taken
were used for statistical analysis. When the recordings of tremor had been
completed blood samples were taken for assay of serum primidone and
phenobarbitone concentrations. Statistical analysis of the data was perform'ed
using Wilcoxon's test for paired differences.
The frequency of the dominant peak of the tremor of the more affected
hand ranged between 4-6 and 8-15 Hz (median 5-95 Hz) and the magnitude
from 11-02 to 675-29 mg (median 30 55 mg). When the difference in magni-
tude was calculated as the absolute change value primidone was significantly
superior to placebo (p < 0-01). In 10 patients the magnitude of tremor was
lower when they received primidone compared with placebo (figure). The
median reduction of the magnitude produced by primidone was 65-99%
of the placebo value (range 12-7-98-7%; p< 0-01). No significant difference in
the frequency of tremor was evident during primidone and placebo treat-
ments.
Owing to dose-related side effects only seven patients achieved the maxi-
mum permitted dosage of primidone. The mean daily dosage for the whole
group was 590 (range 125-750) mg daily. Serum concentrations of pheno-
barbitone ranged between 5 and 87 itmol/l (median 44 ,tmol/l) and of primi-
done between 18 and 100 ,mol/l (median 49 ,umol/l). Side effects occurred
with primidone in six patients and consisted of a variable combination of
sedation, tiredness, nausea, and giddiness; these were attenuated with self-
reduction of dosage. In two patients, who were severely affected, tremor was
reduced by more than 90% of control values to within the range of physio-
logical tremor (figure). These patients did not experience any side effects
while taking the maximum doses of primidone.
Subsequently 10 patients were put on maintenance treatment with primi-
done and followed up for a minimum of six months while taking the drug.
All maintained satisfactory improvement.
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Effect of primidone on magnitude of hand tremor in 11 patients with essential
tremor (figures are root mean squares).
Comment
Our results support the findings of others2 3 that primidone con-
sistently improves essential tremor and may be of value in long-term
symptomatic control of this condition. It may represent an alternative
to propranolol, hitherto the drug of choice in this disorder, particularly
in patients in whom beta-adrenoceptor-blocking drugs are contra-
indicated.
A previous study5 failed to show any significant effect of phenyl-
ethylmalonamide, a major metabolite of primidone, in essential
tremor; it remains to be established, therefore, whether the tremorlytic
effect of primidone is mediated by the parent drug itself or by derived
phenobarbitone, or both.
Further studies are under way to determine whether a range of
plasma concentrations of primidone or derived phenobarbitone may
be established correlating with clinical effect.
Murray TJ. Essential tremor. In: Barbeau A, ed. Disorders of movement.
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2 O'Brien MD, Upton AR, Toseland PA. Benign familial tremor treated
with primidone. Br Med Jf 198 1;282:178-80.
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J Neurol Neurosurg Psychiatry 1981 ;44:650.
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